LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 33 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,000 | -99.9% | 10,000 | -99.9% | 0.00% | -100.0% |
| Q2 2021 | $14,802,000 | -71.7% | 15,000,000 | -70.3% | 0.29% | -74.5% |
| Q1 2021 | $52,330,000 | +3.1% | 50,581,000 | -5.4% | 1.13% | +4.3% |
| Q4 2020 | $50,779,000 | -0.5% | 53,485,000 | -4.8% | 1.08% | -3.8% |
| Q3 2020 | $51,013,000 | +92.0% | 56,178,000 | +84.2% | 1.12% | +80.6% |
| Q2 2020 | $26,576,000 | +539.8% | 30,500,000 | +510.0% | 0.62% | +592.2% |
| Q1 2020 | $4,154,000 | -92.1% | 5,000,000 | -91.8% | 0.09% | -91.2% |
| Q4 2019 | $52,832,000 | +0.3% | 60,954,000 | -3.4% | 1.02% | +3.6% |
| Q3 2019 | $52,698,000 | -10.2% | 63,124,000 | -7.1% | 0.99% | -13.0% |
| Q2 2019 | $58,675,000 | – | 67,972,000 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 40,000,000 | $38,988,000 | 1.44% |
| Penn Mutual Asset Management, LLC | 1,204,000 | $1,174,000 | 1.36% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,148,000 | 0.96% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,006,000 | $9,832,000 | 0.23% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,431,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 20,353,000 | $19,882,000 | 0.21% |
| Wellesley Asset Management | 2,304 | $2,245,000 | 0.15% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,719,000 | 0.12% |
| SSI INVESTMENT MANAGEMENT LLC | 2,000,000 | $1,942,000 | 0.11% |
| Cutler Capital Management, LLC | 300,000 | $291,000 | 0.10% |